New scan could reveal hidden benefits of PAH drug
NCT ID NCT06351345
Summary
This study is testing whether a special type of lung scan using xenon gas can better measure how well a new drug (sotatercept) works for people with pulmonary arterial hypertension (PAH). Researchers will scan the lungs of 14 participants before they start the drug and again after 3 and 12 months. The goal is to see if this scan can detect improvements in lung blood vessels more accurately than current tests, which could help doctors personalize treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke University Medical Center
RECRUITINGDurham, North Carolina, 27710, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.